Melinda Gates’ Investment Firm Backs Magnify Ventures’ $46.6M Fund II

Magnify Ventures closed its second institutional fund at $46.6 million on July 1, 2026, with backing from Pivotal Ventures—the organization founded by Melinda French Gates—to deploy capital into AI infrastructure companies transforming health, wealth, and family care. The Los Angeles-based venture firm targets an inflection point where artificial intelligence replaces today’s fragmented care systems, marking a significant scaling of its investment thesis after the success of its initial $52 million fund.

A $46.6 Million War Chest for Care Economy AI

Magnify Ventures announced the closure of Fund II with a focused mandate: building the artificial intelligence infrastructure layer that will underpin the care economy. The fund represents a strategic bet that AI technology will fundamentally restructure how health services, wealth management, and family caregiving operate across fragmented market segments. Pivotal Ventures returned as a leading limited partner, signaling continued institutional confidence in Magnify’s thesis and market timing.

Beyond Pivotal Ventures, new investors joined the fund’s capitalization table, including Jordan Park and Unum, alongside financing from the California Infrastructure and Economic Development Bank. Combined with Fund I’s $52 million deployment, Magnify Ventures has now mobilized nearly $100 million into care economy Startups. Fund I resulted in 21 investments across pre-seed, seed, and seed-plus stages, while Fund II enters the market in a pre-investment phase, positioned to capitalize on accelerating AI adoption in care sectors.

Strategic Alignment with Melinda French Gates’ Philanthropic Vision

Pivotal Ventures’ participation in Fund II extends Melinda French Gates’ broader strategic commitment to advancing women’s power and influence globally. In 2026, Gates announced a $1 billion philAnthropic commitment through the organization, with $250 million dedicated to Action for Women’s Health—a global open call designed to improve women’s mental and physical health outcomes. This philAnthropic framework directly aligns with Magnify’s focus on family care, caregiver support, and health innovation, creating a coordinated investment and impact strategy.

The backing from Pivotal Ventures underscores how institutional capital increasingly converges with philanthropic objectives in the care economy. Rather than treating venture investment and charitable giving as separate tracks, Melinda French Gates’ organization uses both mechanisms to address systemic gaps in care infrastructure. Fund II’s AI infrastructure focus complements this vision by targeting the technological foundation that will enable scalable, accessible care solutions for underserved populations.

Portfolio Momentum and Investment Categories

Magnify Ventures’ existing portfolio companies demonstrate early traction in the care economy segments the firm targets. Portfolio holdings include Nolia Health, which provides caregiver support technology, and MiSalud, a digital health platform serving Spanish-speaking communities. These investments illustrate Magnify’s commitment to both mainstream care challenges and equity-focused solutions that reach underrepresented populations.

Fund II will deploy capital across four primary investment categories: Future of Families, Aging Innovation, Household Optimization, and Work-Life Reimagined. The firm typically writes checks ranging from $100,000 to $2 million at pre-seed, seed, and seed-plus stages. This check size and stage focus position Magnify as a category-focused early-stage investor rather than a broad-based generalist, allowing the firm to develop deep expertise in care economy dynamics and AI application opportunities within that vertical.

Building the Care Infrastructure Layer

Magnify’s Fund II thesis centers on a specific market gap: the absence of AI infrastructure purpose-built for care systems. Today’s health, family care, and wealth management sectors operate through legacy systems that rarely communicate with one another. Fund II capital will target companies developing the middleware, platforms, and integrated systems that consolidate fragmented care delivery into coherent, AI-enabled experiences.

This infrastructure focus distinguishes Fund II from Venture Capital that invests in point solutions or consumer-facing care applications. Instead, Magnify targets the foundational technology layer that multiple care providers and family units will eventually depend on. The $46.6 million fund size reflects confidence that sufficient market demand exists for category-defining companies in this space, even as the AI care infrastructure market remains nascent.

Fund I’s Track Record Sets Expectations for Fund II

Magnify Ventures’ Fund I deployed $52 million across 21 investments, establishing a reference point for evaluating Fund II’s potential impact. The slightly smaller Fund II capitalization—$46.6 million versus $52 million—suggests a more selective or cautious deployment strategy rather than accelerated growth. This approach may reflect lessons learned from Fund I, where the firm likely identified specific subsectors within the care economy showing stronger product-market fit and scaling potential.

The two-fund progression also marks Magnify’s evolution from a Silicon Valley startup founded in 2020 to an established Los Angeles-based institutional investor. With nearly $100 million deployed across two funds, Magnify has accumulated sufficient portfolio data and market insight to refine its investment criteria for Fund II. The transition from Fund I’s exploratory phase to Fund II’s focused execution phase suggests the firm has identified clear patterns in which care economy segments respond most effectively to AI-driven transformation.

Next Moves in AI-Driven Care

The fund closure positions Magnify Ventures to begin deploying capital into the pre-seed and seed-stage companies it has identified during its fundraising period. With new limited partners including Jordan Park and Unum now committed, the firm enters deployment with fresh capital and expanded institutional networks. The coming months will reveal which care economy subsectors Magnify prioritizes first and which AI infrastructure problems it judges most acute.

Fund II’s timing coincides with accelerating AI adoption across healthcare and care sectors globally. As large technology companies and healthcare incumbents invest heavily in AI applications, early-stage venture capital targeting AI infrastructure for fragmented care systems faces both opportunity and competitive pressure. Magnify Ventures’ $46.6 million fund, backed by Pivotal Ventures and aligned with Melinda French Gates’ philanthropic priorities, positions the firm to influence how AI reshapes care delivery for years ahead.